Dr. Hutter: Hello. Welcome to Conversations with Experts; I'm Dolph Hutter. Today we're talking about "Clopidogrel Resistance: Its Significance and Management." With me is Dr. Gilles Montalescot ...
Inspired by the myriad of people trying out the 75 Hard Challenge on your social feed? It’s hard not to be, especially when you’re looking at those progress pics. But, what is 75 Hard ...
Speaking to The Straits Times in an exclusive interview on Jan 9 at MG’s exhibition booth at Suntec Singapore Convention and Exhibition Centre, the 76-year-old motor tycoon is driven to take a ...
WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...
ABU DHABI, 6th June, 2017 (WAM) -- The UAE Ministry of Health and Prevention has issued a circular to all medical facilities and hospitals to withdraw Brilinta 90 mg batch number JB504 by AstraZeneca ...
– Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drivers of inflammation and fibrosis – – Pivotal data from the AGAVE-201 trial ...
If you’re reading this and you have TikTok, I guarantee you’ll have heard of 75 Hard. The challenge has ... and the water intake was so generic; a 100kg individual would be drinking the ...
The approved dose of Niktimvo for adults and pediatric patients weighing at least 40 kg is 0.3 mg/kg, up to a maximum dose of 35 mg, as an intravenous infusion over 30 minutes every two weeks.
MG has returned to the South African market after it exited the country in 2016. The former British brand belongs to Shanghai giant, SAIC Motor, which acquired it in in 2007. MG Motor South Africa ...
LONDON, Jan 15 (Reuters) - The chief executive of Airbus (AIR.PA), opens new tab said he was confident the company would reach its target of manufacturing 75 single-aisle aircraft a month in 2027 ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...